These emerging medications , including Semaglutide , belong to a group of drugs called GLP-1 agents. Originally developed for controlling diabetes mellitus , they operate by encouraging the pancreas to produce more the hormone insulin and curbing excessive glucose levels. Beyond diabetes, their capacity to promote slimming has resulted to substanti